本文已被:浏览 241次 下载 166次
投稿时间:2026-06-09 网络发布日期:2026-10-23
投稿时间:2026-06-09 网络发布日期:2026-10-23
中文摘要: 目的 探讨行根治性手术切除的ⅠB期肺腺癌患者的临床特点,并分析影响其预后的因素。方法 回顾性分析2016年1月至2020年12月在徐州市中心医院接受肺癌根治术105例ⅠB期肺腺癌患者的临床资料。根据术后是否接受辅助治疗分为观察组(n=41)和辅助治疗组(n=64),比较两组的临床特征。根据辅助治疗方式将辅助治疗组分为联合治疗亚组(n=25)、辅助化疗亚组(n=27)和辅助靶向治疗亚组(n=12)。采用Kaplan-Meier法绘制生存曲线,使用log-rank检验分别比较两个组和三个亚组的总生存(OS)率和无病生存(DFS)率。采用Cox 比例风险回归模型分析ⅠB 期肺腺癌OS 的影响因素。结果 观察组与辅助治疗组在分化程度、淋巴结清扫数量、血管内癌栓及淋巴管内癌栓方面差异有统计学意义(P<0.05)。观察组和辅助治疗组的5 年OS 率(73.2% vs 83.8%,P=0.193)和3 年DFS 率差异无统计学意义(65.9% vs 70.3%,P=0.676)。三个亚组的5 年OS 率和3 年DFS 率差异亦无统计学意义(P>0.05)。多因素Cox 回归分析显示肿瘤位置(中下叶)[RR:1.620(1.116~2.352),P=0.011]和淋巴结清扫数量>10[RR:0.078(0.022~0.279),P<0.01]是影响患者OS 的独立预后因素。结论 目前ⅠB 期肺腺癌患者术后5 年OS 率仍不理想,合并复发高危因素的患者更倾向于选择术后辅助治疗。与未行辅助治疗的患者相比,尽管从生存曲线上看,术后辅助治疗有延长患者OS和DFS的潜在可能,但差异无统计学意义。肿瘤位置、淋巴结清扫数量这两项指标是影响患者预后的重要因素。
Abstract:Objective To investigate the clinical characteristics of patients with stage ⅠB lung adenocarcinoma who underwent radical surgical resection and to analyze factors affecting their prognosis. Methods The clinical data of 105 patients who underwent radical surgery for ⅠB lung adenocarcinoma at Xuzhou Central Hospital from January 2016 to December 2020 were retrospectively analyzed. Patients were divided into an observation group(n=41)and an adjuvant therapy group (n=64)according to whether they received postoperative adjuvant therapy,and the clinical characteristics of the two groups were compared. According to the adjuvant treatment modality,the adjuvant therapy group was divided into a combination therapy subgroup(n=25),an adjuvant chemotherapy subgroup(n=27),and an adjuvant targeted therapy subgroup(n=12). The Kaplan-Meier method was used to plot survival curves,and the log-rank test was used to compare overall survival(OS)and disease-free survival(DFS)rates between the two groups and among the three subgroups,respectively. A Cox proportional hazards regression model was used to analyze factors affecting OS of stage ⅠB lung adenocarcinoma patients. Results Statistically significant differences were found between the observation group and the adjuvant therapy group in differentiation degree,number of dissected lymph nodes,intravascular tumor thrombi,and intralymphatic tumor thrombi(P<0.05). No statistically significant differences were found in the 5-year OS rate(73.2% vs 83.8%,P=0.193)or 3-year DFS rate(65.9% vs 70.3%,P=0.676)between the observation group and the adjuvant therapy group. No statistically significant differences were found in the 5-year OS rate or 3-year DFS rate among the three subgroups either(P>0.05). Multivariate Cox regression analysis showed that tumor location(middle and lower lobes)[RR:1.620(1.116- 2.352),P=0.011]and number of dissected lymph nodes >10 [RR:0.078(0.022- 0.279),P<0.01]were independent prognostic factors affecting patients 'OS.Conclusion Currently,the 5-year postoperative survival rate of patients with stage ⅠB lung adenocarcinoma remains unsatisfactory,and patients with high-risk factors for recurrence are more inclined to choose postoperative adjuvant therapy. Compared with the patients without adjuvant therapy,although the survival curves suggest that postoperative adjuvant therapy may prolong OS and DFS,the difference was not statistically significant. Tumor location and number of dissected lymph nodes are important factors affecting patients'prognosis.
keywords: Lung adenocarcinoma Radical operation of lung cancer Disease-free survival rate Lymph node dissection Tumor location Adjuvant therapy Targeted therapy Chemotherapy
文章编号: 中图分类号:R734.2 文献标志码:A
基金项目:
附件
| 作者 | 单位 |
| 李晓武 | 1. 东南大学附属徐州市中心医院肿瘤内科,江苏 徐州 221009 |
| 袁媛 | 1. 东南大学附属徐州市中心医院肿瘤内科,江苏 徐州 221009 |
| 牛广才 | 2. 东南大学附属徐州市中心医院胃肠外科,江苏 徐州 221009 |
| Author Name | Affiliation |
| LI Xiaowu*,YUAN Yuan,NIU Guangcai | *Department of Medical Oncology,Xuzhou Central Hospital of Southeast University,Xuzhou,Jiangsu 221009,China |
引用文本:
李晓武,袁媛,牛广才.ⅠB期肺腺癌105例患者的临床特点及预后分析[J].中国临床研究,2026,39(10):1507-1511.
李晓武,袁媛,牛广才.ⅠB期肺腺癌105例患者的临床特点及预后分析[J].中国临床研究,2026,39(10):1507-1511.
